"KRAS mutations" trang 1 - tải miễn phí từ tailieunhanh
The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: A retrospective analysis

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: A retrospective analysis
8    80    1
Research on KRAS mutations in patients with colorectal polyps larger than 10 mm

Research on KRAS mutations in patients with colorectal polyps larger than 10 mm
11    9    1
Associations between nutritional factors and KRAS mutations in colorectal cancer: A systematic review

Associations between nutritional factors and KRAS mutations in colorectal cancer: A systematic review
21    35    1
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
7    66    1
The impact of KRAS mutations on VEGF-A production and tumour vascular network

The impact of KRAS mutations on VEGF-A production and tumour vascular network
11    44    1
Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
11    5    1
ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours
8    67    1
A case report of an unusual non-mucinous papillary variant of CPAM type 1 with KRAS mutations

A case report of an unusual non-mucinous papillary variant of CPAM type 1 with KRAS mutations
4    41    1
Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma

Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma
10    4    1
Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: Associations with environmental factors and clinical outcomes
9    1    1
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
6    54    1
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer

A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
9    25    1
Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer
11    38    1
BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients

BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients
12    38    1
Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component

Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component
7    51    0
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)
11    90    1
Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform

Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform
8    69    1
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
11    57    1
Copy number of the adenomatous polyposis coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene

Copy number of the adenomatous polyposis coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene
8    48    1
Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit

Simultaneous identification of 36 mutations in KRAS codons 61and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit
9    54    1